Ascend Wellness Holdings, Inc. (OTC:AAWH - Get Free Report) was the target of a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 5,700 shares, a drop of 59.6% from the August 15th total of 14,100 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company's stock are short sold. Currently, 0.0% of the company's stock are short sold. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is presently 0.0 days.
Ascend Wellness Stock Performance
Shares of AAWH traded up $0.06 during trading hours on Thursday, hitting $0.67. The stock had a trading volume of 49,561 shares, compared to its average volume of 164,323. The company has a debt-to-equity ratio of 2.61, a current ratio of 1.47 and a quick ratio of 0.80. Ascend Wellness has a 12 month low of $0.26 and a 12 month high of $1.02. The firm has a market capitalization of $135.95 million, a PE ratio of -1.62 and a beta of 1.15. The stock has a fifty day moving average price of $0.57 and a 200 day moving average price of $0.41.
Wall Street Analyst Weigh In
Separately, Zacks Research raised Ascend Wellness to a "strong sell" rating in a report on Tuesday, August 12th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of "Sell".
Read Our Latest Analysis on AAWH
Ascend Wellness Company Profile
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
Read More
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.